Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
Ragon Institute Brings New Perspectives to Vaccine Development Medical Countermeasures March 4, 2013 …
SEB Biodefense Vaccine Starts First Human Clinical Trial Antimicrobial Resistance February 26, 2013 …
Breakthrough Discovery on Target to Block Staphylococcus Infection Medical Countermeasures February 11, 2013 …
One Lump or Two? Sucrose Micro Disc for Injection-Free Vaccines Medical Countermeasures February 7, 2013 …
DHS Seeks Contractor for Agricultural Biodefense Efforts at Plum Island Biosecurity February 6, 2013 …
Tetravalent Dengue Vaccine Candidate Shows Promise in Early Trials Medical Countermeasures January 28, 2013 …
Emergent BioSolutions Secures Rights to Pandemic Influenza Vaccine Candidate Industry News January 8, 2013 …
